Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)
ClinicalTrials.gov study NCT02363751. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy
ClinicalTrials.gov study NCT04180033. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of AK104 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer
ClinicalTrials.gov study NCT04982237. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT01033123. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MITO-6: Capecitabine in Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT00403429. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensit
ClinicalTrials.gov study NCT01767675. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT03056833. IPD Sharing: NO. Countries: 1. Publications: 1.
Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT01802749. IPD Sharing: Not stated. Countries: 5. Publications: 3.
An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell
ClinicalTrials.gov study NCT03823625. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers
ClinicalTrials.gov study NCT04795596. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)
ClinicalTrials.gov study NCT03398655. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
ClinicalTrials.gov study NCT04575961. IPD Sharing: YES. Countries: 1. Publications: 0.
Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
ClinicalTrials.gov study NCT03534453. IPD Sharing: YES. Countries: 2. Publications: 2.
Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.
ClinicalTrials.gov study NCT03467178. IPD Sharing: NO. Countries: 1. Publications: 33.
A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer
ClinicalTrials.gov study NCT05179239. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT01166737. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or Intolerant to Platinum-based Combination Therapy
ClinicalTrials.gov study NCT07347314. IPD Sharing: NO. Countries: 1. Publications: 1.
Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer
ClinicalTrials.gov study NCT00216112. IPD Sharing: NO. Countries: 1. Publications: 1.
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
ClinicalTrials.gov study NCT03064854. IPD Sharing: NO. Countries: 12. Publications: 1.
Validation of a Score of Predictive Factors for Complete Resection in Platinum-sensitive Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT00368420. IPD Sharing: Not stated. Countries: 4. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.